FOS and colonic neoplasm: Similarly, kaempferol reversed the oxaliplatin resistance in human colon cancer cells by inhibiting the expression of A Jun and Fos heterodimers (AP-1), which are involved in growth factor-mediated cell cycle progression and cell proliferation [70].